Researchers Caution against Unrealistic Claims of Home Genetic Tests

Direct to consumer (DTC) genetic tests are increasingly being marketed to the public via television, print ads, and the Internet. These home genetic tests provide access to a person's genomic information without necessarily involving a doctor or insurance company in the process.

Writing in the August 18, 2010, online, first edition of the New England Journal of Medicine, medical geneticist James P. Evans, M.D., Ph.D. from the University of North Carolina at Chapel Hill School of Medicine and the UNC Lineberger Comprehensive Cancer Center, and co-authors David C. Dale, MD from the University of Washington, and Cathy Fomous, Ph.D. from the National Institutes of Health, state that medical professionals "must ensure that rapidly evolving and multiplying genomic technologies are responsibly harnessed and that their promise is not oversold to the public."

In their article, titled "Preparing for a Consumer-Driven Genomic Age," the authors argue that "a primary role of health care professionals in the future may be to interpret their patients' DTC genetic test results and advise them about appropriate follow-up."

While the authors acknowledge that individuals should continue to be permitted direct access to their genomic information, they note that "consumers must be protected from unrealistic claims and the misinterpretation of complex and dynamic genomic information."

Noting that segments of the public already embrace DTC genetic tests, the authors point out that in many cases, there is "little or no evidence of the clinical validity of tests developed from genetic technologies." The authors state that clinical validity data "are limited because they can be difficult and expensive to obtain and because there is no FDA requirement for the premarketing submission of such data for most genetic tests."

In testimony last month to the House Energy and Commerce Subcommittee on Oversight and Investigations, Evans stressed that consumers "deserve an honest accounting of what such information means and the assurance that it is derived in a manner that ensures quality, reliability and confidentiality."

Product Showcase

  • SECUPRO MARTEGO

    FOR HIGHEST DEMANDS. A cutting tool in which function and design go hand in hand. Meet the SECUPRO MARTEGO, our prize-winning squeeze-grip safety knife with fully automatic retractable blade for safety. • Ergonomically friendly trigger mechanism to engage the blade • Durable body made of aluminum • Safer alternative to fixed blade utility knives for general cutting tasks • 9 mm Cutting depth • Easy, tool free blade change Dimensions: L 6.10" L x 0.71" W x 1.91" H Weight: 3.70 oz Cutting Depth: 9 mm Read More

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

  • Matrix's OmniPro Vision AI Collision Avoidance System

    OmniPro Vision AI is a state-of-the-art collision avoidance system that features NIOSH award-winning Visual Artificial Intelligence (AI) technology. This highly accurate, powerful system identifies and alerts on pedestrians, vehicles and specified objects, ensuring safer facilities, mining operations and industrial sites. With its web-based cloud application, OmniPro Vision AI also logs and analyzes a wide range of data related to zone breach notifications. Operating without needing personal wearable devices or tags, OmniPro has visual and audible zone breach alerts for both operators and pedestrians. Read More

Featured

Artificial Intelligence